{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:06:32Z","timestamp":1788977192667,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic Obstructive Pulmonary Disease (COPD) imposes substantial economic costs. Cost-effectiveness evaluations in COPD frequently rely on Markov (or other state-transition) models. Their accuracy relies on precise mortality probabilities by COPD grade. The aim of this systematic review was to provide evidence-based hazard ratios (HRs) for grade-specific mortality (GOLD 1\u20134 at baseline) and to derive grade-, age-, and sex-specific mortality probabilities for patients with COPD in Germany. A systematic PubMed and Europe PMC search was conducted for studies published between 2003 and February 2026. HRs were standardized to the reference group of normal spirometry and pooled by GOLD grade using network meta-analysis. We derived grade-specific mortality probabilities for Germany stratified by 5-year age-groups and sex by combining the pooled HRs with age- and sex-specific German period life-table mortality from the German Federal Statistical Office. Risk of bias was assessed by the Newcastle\u2013Ottawa Scale. In total, 1,459,685 participants from 34 publications were included, with 966,144 having normal spirometry and the others classified into GOLD grades 1\u20134 at baseline. We found a monotonic increase in mortality with grade, with HRs (95% CIs) of 1.09 (0.97\u20131.22), 1.57 (1.41\u20131.75), 2.39 (2.03\u20132.83), and 4.54 (3.44\u20136.01) in GOLD 1\u20134, respectively. Estimated 1-year mortality probabilities for patients with COPD in Germany ranged from 0.15% (females, GOLD 1, ages 45\u201349) to 64.8% (GOLD 4, males, age\u2009\u2265\u200985). This study provides evidence-based mortality risks for patients with COPD in Germany, stratified by grade, age, and sex, while presenting a transferable framework for deriving similar mortality probabilities in other countries.<\/jats:p>","DOI":"10.1038\/s41598-026-68641-0","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:04:05Z","timestamp":1788973445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimation of mortality hazard ratios by COPD grade using a systematic review and network meta-analysis: deriving grade-, sex-, and age-specific mortality for a German COPD decision model"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7990-3437","authenticated-orcid":false,"given":"Tobias","family":"Niedermaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"68641_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00117-2017","author":"A Agusti","year":"2017","unstructured":"Agusti, A. & Celli, B. Natural history of COPD: gaps and opportunities. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00117-2017 (2017).","journal-title":"ERJ Open Res."},{"key":"68641_CR2","unstructured":"Agusti, A. et al. Global initiative for chronic obstructive lung disease 2024 report: 2023, 2024 Global Initiative for Chronic Obstructive Lung Disease, Inc. https:\/\/goldcopd.org\/2024-gold-report\/ (2024)."},{"key":"68641_CR3","doi-asserted-by":"publisher","unstructured":"Steppuhn, H., Kuhnert, R. & Scheidt-Nave, C. 12-month prevalence of known chronic obstructive pulmonary disease (COPD) in Germany. J. Health Monit. 2 (3), 43\u201350. https:\/\/doi.org\/10.17886\/rki-gbe-2017-065 (2017).","DOI":"10.17886\/rki-gbe-2017-065"},{"issue":"3","key":"68641_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/ijcp.12522","volume":"69","author":"T Welte","year":"2015","unstructured":"Welte, T., Vogelmeier, C. & Papi, A. COPD: early diagnosis and treatment to slow disease progression. Int. J. Clin. Pract. 69(3), 336\u2013349. https:\/\/doi.org\/10.1111\/ijcp.12522 (2015).","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"68641_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jval.2016.08.003","volume":"20","author":"Z Zafari","year":"2017","unstructured":"Zafari, Z. et al. A systematic review of health economics simulation models of chronic obstructive pulmonary disease. Value Health 20(1), 152\u2013162. https:\/\/doi.org\/10.1016\/j.jval.2016.08.003 (2017).","journal-title":"Value Health"},{"issue":"9","key":"68641_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/11591340-000000000-00000","volume":"30","author":"P Menn","year":"2012","unstructured":"Menn, P., Leidl, R. & Holle, R. A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease. Pharmacoeconomics 30(9), 825\u2013840. https:\/\/doi.org\/10.2165\/11591340-000000000-00000 (2012).","journal-title":"Pharmacoeconomics"},{"key":"68641_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71. https:\/\/doi.org\/10.1136\/bmj.n71 (2021).","journal-title":"BMJ"},{"key":"68641_CR8","unstructured":"Agusti, A. C et al. Global initiative for chronic obstructive lung disease: 2024 pocket guide 2024. https:\/\/goldcopd.org\/2024-gold-report\/."},{"key":"68641_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-35","volume":"13","author":"U Krahn","year":"2013","unstructured":"Krahn, U., Binder, H. & Konig, J. A graphical tool for locating inconsistency in network meta-analyses. BMC Med. Res. Methodol. 13, 35. https:\/\/doi.org\/10.1186\/1471-2288-13-35 (2013).","journal-title":"BMC Med. Res. Methodol."},{"key":"68641_CR10","unstructured":"Gestorbene: Deutschland, Jahre, Geschlecht, Altersjahre (code 12613\u20130003) [database on the Internet] (2023). https:\/\/www-genesis.destatis.de\/genesis\/online?operation=find&suchanweisung_language=de&query=Gestorbene#abreadcrumb."},{"key":"68641_CR11","unstructured":"Fortschreibung des Bev\u00f6lkerungsstandes (code: 12411\u20130006) [database on the Internet] (2023). https:\/\/www-genesis.destatis.de\/genesis\/online\/statistic\/12411*#abreadcrumb."},{"issue":"5","key":"68641_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/thorax.58.5.388","volume":"58","author":"DM Mannino","year":"2003","unstructured":"Mannino, D. M., Buist, A. S., Petty, T. L., Enright, P. L. & Redd, S. C. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58(5), 388\u2013393. https:\/\/doi.org\/10.1136\/thorax.58.5.388 (2003).","journal-title":"Thorax"},{"issue":"1","key":"68641_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-98","volume":"6","author":"M Ekberg-Aronsson","year":"2005","unstructured":"Ekberg-Aronsson, M., Pehrsson, K., Nilsson, J. A., Nilsson, P. M. & Lofdahl, C. G. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir. Res. 6(1), 98. https:\/\/doi.org\/10.1186\/1465-9921-6-98 (2005).","journal-title":"Respir. Res."},{"issue":"1","key":"68641_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.rmed.2005.03.035","volume":"100","author":"DM Mannino","year":"2006","unstructured":"Mannino, D. M., Doherty, D. E. & Sonia Buist, A. Global initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir. Med. 100(1), 115\u2013122. https:\/\/doi.org\/10.1016\/j.rmed.2005.03.035 (2006).","journal-title":"Respir. Med."},{"issue":"2","key":"68641_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1378\/chest.130.2.318","volume":"130","author":"K Stavem","year":"2006","unstructured":"Stavem, K., Sandvik, L. & Erikssen, J. Can global initiative for chronic obstructive lung disease stage 0 provide prognostic information on long-term mortality in men?. Chest 130(2), 318\u2013325. https:\/\/doi.org\/10.1378\/chest.130.2.318 (2006).","journal-title":"Chest"},{"issue":"4","key":"68641_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/15412550903061483","volume":"6","author":"B Lundback","year":"2009","unstructured":"Lundback, B. et al. A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. COPD J. Chronic Obstr. Pulm. Dis. 6(4), 263\u2013271. https:\/\/doi.org\/10.1080\/15412550903061483 (2009).","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"issue":"3","key":"68641_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/1479972310368692","volume":"7","author":"I Alfageme","year":"2010","unstructured":"Alfageme, I. et al. The effect of airflow limitation on the cause of death in patients with COPD. Chron. Respir. Dis. 7(3), 135\u2013145. https:\/\/doi.org\/10.1177\/1479972310368692 (2010).","journal-title":"Chron. Respir. Dis."},{"issue":"1","key":"68641_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-136","volume":"12","author":"DM Mannino","year":"2011","unstructured":"Mannino, D. M., Diaz-Guzman, E. & Buist, S. Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Respir. Res. 12(1), 136. https:\/\/doi.org\/10.1186\/1465-9921-12-136 (2011).","journal-title":"Respir. Res."},{"issue":"4","key":"68641_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/15412555.2012.668249","volume":"9","author":"DM Mannino","year":"2012","unstructured":"Mannino, D. M., Valvi, D., Mullerova, H. & Tal-Singer, R. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. COPD 9(4), 359\u2013366. https:\/\/doi.org\/10.3109\/15412555.2012.668249 (2012).","journal-title":"COPD"},{"issue":"1","key":"68641_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1164\/rccm.201212-2276OC","volume":"188","author":"A Johannessen","year":"2013","unstructured":"Johannessen, A. et al. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am. J. Respir. Crit. Care Med. 188(1), 51\u201359. https:\/\/doi.org\/10.1164\/rccm.201212-2276OC (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"68641_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/thoraxjnl-2013-203270","volume":"68","author":"L Leivseth","year":"2013","unstructured":"Leivseth, L. et al. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT study, Norway. Thorax 68(10), 914\u2013921. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203270 (2013).","journal-title":"Thorax"},{"issue":"8","key":"68641_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.rmed.2015.06.002","volume":"109","author":"T Mattila","year":"2015","unstructured":"Mattila, T. et al. Association between all-cause and cause-specific mortality and the GOLD stages 1-4: a 30-year follow-up among Finnish adults. Respir. Med. 109(8), 1012\u20131018. https:\/\/doi.org\/10.1016\/j.rmed.2015.06.002 (2015).","journal-title":"Respir. Med."},{"issue":"1","key":"68641_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15412555.2016.1206875","volume":"14","author":"M Brusse-Keizer","year":"2017","unstructured":"Brusse-Keizer, M. et al. Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD. COPD 14(1), 7\u201314. https:\/\/doi.org\/10.1080\/15412555.2016.1206875 (2017).","journal-title":"COPD"},{"issue":"3","key":"68641_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S2213-2600(18)30002-X","volume":"6","author":"A Gedebjerg","year":"2017","unstructured":"Gedebjerg, A. et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir. Med. 6(3), 204\u2013212. https:\/\/doi.org\/10.1016\/S2213-2600(18)30002-X (2017).","journal-title":"Lancet Respir. Med."},{"key":"68641_CR25","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.2147\/copd.S175527","volume":"13","author":"R Perez-Padilla","year":"2018","unstructured":"Perez-Padilla, R. et al. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort. Int. J. Chron. Obstruct. Pulmon. Dis.. 13, 3549\u20133561. https:\/\/doi.org\/10.2147\/copd.S175527 (2018).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"68641_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01217-2019","author":"SRA Wijnant","year":"2020","unstructured":"Wijnant, S. R. A. et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam study. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.01217-2019 (2020).","journal-title":"Eur. Respir. J."},{"key":"68641_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2147\/copd.S297087","volume":"16","author":"K Brat","year":"2021","unstructured":"Brat, K. et al. The relation between clinical phenotypes, GOLD groups\/stages and mortality in COPD patients - a prospective multicenter study. Int. J. Chron. Obstruct. Pulmon. Dis. 16, 1171\u20131182. https:\/\/doi.org\/10.2147\/copd.S297087 (2021).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"68641_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/COPD.S296472","volume":"16","author":"M Damkjaer","year":"2021","unstructured":"Damkjaer, M., Hakansson, K., Kallemose, T., Ulrik, C. S. & Godtfredsen, N. Statins in high-risk chronic obstructive pulmonary disease outpatients: no impact on time to first exacerbation and all-cause mortality - the STATUETTE cohort study. Int J Chron Obstruct Pulmon Dis. 16, 579\u2013589. https:\/\/doi.org\/10.2147\/COPD.S296472 (2021).","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"68641_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106471","volume":"184","author":"C Guo","year":"2021","unstructured":"Guo, C. et al. Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: a 21-year longitudinal cohort study. Respir. Med. 184, 106471. https:\/\/doi.org\/10.1016\/j.rmed.2021.106471 (2021).","journal-title":"Respir. Med."},{"issue":"2","key":"68641_CR30","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2021200477","volume":"3","author":"KA Hasenstab","year":"2021","unstructured":"Hasenstab, K. A. et al. Automated CT staging of chronic obstructive pulmonary disease severity for predicting disease progression and mortality with a deep learning convolutional neural network. Radiol. Cardiothorac. Imaging 3(2), e200477. https:\/\/doi.org\/10.1148\/ryct.2021200477 (2021).","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"68641_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.755855","volume":"8","author":"D He","year":"2021","unstructured":"He, D. et al. Different risks of mortality and longitudinal transition trajectories in new potential subtypes of the preserved ratio impaired spirometry: evidence from the english longitudinal study of aging. Front. Med. (Lausanne). 8, 755855. https:\/\/doi.org\/10.3389\/fmed.2021.755855 (2021).","journal-title":"Front. Med. (Lausanne)."},{"issue":"5","key":"68641_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1164\/rccm.202110-2302OC","volume":"206","author":"Y Washio","year":"2022","unstructured":"Washio, Y. et al. Risks of mortality and airflow limitation in Japanese individuals with preserved ratio impaired spirometry. Am. J. Respir. Crit. Care Med. 206(5), 563\u2013572. https:\/\/doi.org\/10.1164\/rccm.202110-2302OC (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"68641_CR33","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.21037\/tlcr-22-63","volume":"11","author":"R Kaaks","year":"2022","unstructured":"Kaaks, R. et al. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality. Transl. Lung Cancer Res. 11(9), 1896\u20131911. https:\/\/doi.org\/10.21037\/tlcr-22-63 (2022).","journal-title":"Transl. Lung Cancer Res."},{"key":"68641_CR34","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.2147\/COPD.S429104","volume":"18","author":"W Cheng","year":"2023","unstructured":"Cheng, W. et al. Prediction of hospitalization and mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2023 group classification: a prospective cohort and a retrospective analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 18, 2341\u20132352. https:\/\/doi.org\/10.2147\/COPD.S429104 (2023).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"68641_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02841-y","volume":"25","author":"CJ Cadham","year":"2007","unstructured":"Cadham, C. J. et al. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012. Respir. Res. 25(1), 208. https:\/\/doi.org\/10.1186\/s12931-024-02841-y (2007).","journal-title":"Respir. Res."},{"issue":"3","key":"68641_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/thorax-2022-219320","volume":"79","author":"H Whittaker","year":"2024","unstructured":"Whittaker, H., Rothnie, K. J. & Quint, J. K. Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax 79(3), 202\u2013208. https:\/\/doi.org\/10.1136\/thorax-2022-219320 (2024).","journal-title":"Thorax"},{"key":"68641_CR37","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01289-2024","author":"L Egerod","year":"2025","unstructured":"Egerod, L. et al. Comorbidity profiles in chronic obstructive pulmonary disease: a multicohort study. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.01289-2024 (2025).","journal-title":"ERJ Open Res."},{"issue":"9","key":"68641_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/resp.70052","volume":"30","author":"K Hyung","year":"2025","unstructured":"Hyung, K. et al. Impact of the race-neutral equation on mortality risk prediction in Korean patients with chronic obstructive pulmonary disease. Respirology 30(9), 831\u2013839. https:\/\/doi.org\/10.1111\/resp.70052 (2025).","journal-title":"Respirology"},{"issue":"6","key":"68641_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10654-025-01252-7","volume":"40","author":"Y Ke","year":"2025","unstructured":"Ke, Y. et al. All-cause and cause-specific mortality in individuals with COPD in China: a 16-year follow-up cohort study. Eur. J. Epidemiol. 40(6), 681\u2013691. https:\/\/doi.org\/10.1007\/s10654-025-01252-7 (2025).","journal-title":"Eur. J. Epidemiol."},{"key":"68641_CR40","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.15.04152","volume":"15","author":"CH Lin","year":"2023","unstructured":"Lin, C. H. et al. Prognostic risk profiling in COPD using Global Initiative for Chronic Obstructive Lung Disease 2023 ABE and comorbidity assessment: evidence from a register-based COPD cohort. J. Glob. Health 15, 04152. https:\/\/doi.org\/10.7189\/jogh.15.04152 (2023).","journal-title":"J. Glob. Health"},{"key":"68641_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002818","author":"J Ma","year":"2025","unstructured":"Ma, J. et al. Independent and joint relationships of physical activity and pulmonary function with the risk of all-cause mortality. BMJ Open Respir. Res. https:\/\/doi.org\/10.1136\/bmjresp-2024-002818 (2025).","journal-title":"BMJ Open Respir. Res."},{"key":"68641_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108280","volume":"247","author":"T Niedermaier","year":"2025","unstructured":"Niedermaier, T., Alter, P., Jorres, R., Vogelmeier, C. & Holle, R. Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: results from COSYCONET. Respir. Med. 247, 108280. https:\/\/doi.org\/10.1016\/j.rmed.2025.108280 (2025).","journal-title":"Respir. Med."},{"issue":"1","key":"68641_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05033-w","volume":"15","author":"H Ogata","year":"2025","unstructured":"Ogata, H. et al. Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study. Sci. Rep. 15(1), 19097. https:\/\/doi.org\/10.1038\/s41598-025-05033-w (2025).","journal-title":"Sci. Rep."},{"key":"68641_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101322","volume":"54","author":"O Wallstrom","year":"2025","unstructured":"Wallstrom, O. et al. Risk of exacerbations, hospitalisation, and mortality in adults with physician-diagnosed chronic obstructive pulmonary disease with normal spirometry and adults with preserved ratio impaired spirometry in Sweden: retrospective analysis of data from a nationwide cohort study. Lancet Reg Health Eur. 54, 101322. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101322 (2025).","journal-title":"Lancet Reg Health Eur."},{"issue":"1","key":"68641_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.arbres.2025.05.004","volume":"62","author":"C Casanova","year":"2026","unstructured":"Casanova, C. et al. Lung diffusing capacity improves the prognostic validity of the GOLD spirometric staging in COPD. Arch. Bronconeumol. 62(1), 20\u201327. https:\/\/doi.org\/10.1016\/j.arbres.2025.05.004 (2026).","journal-title":"Arch. Bronconeumol."},{"key":"68641_CR46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00561-2019","author":"C Janson","year":"2019","unstructured":"Janson, C. et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00561-2019 (2019).","journal-title":"Eur. Respir. J."},{"issue":"1","key":"68641_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jrsm.5","volume":"1","author":"LV Hedges","year":"2010","unstructured":"Hedges, L. V., Tipton, E. & Johnson, M. C. Robust variance estimation in meta-regression with dependent effect size estimates. Res. Synth. Methods 1(1), 39\u201365. https:\/\/doi.org\/10.1002\/jrsm.5 (2010).","journal-title":"Res. Synth. Methods"},{"issue":"2","key":"68641_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00408-019-00196-6","volume":"197","author":"M Plutinsky","year":"2019","unstructured":"Plutinsky, M. et al. Prognostic accuracy of three COPD classification systems in relation to long-term mortality of COPD patients: a prospective multicenter study. Lung 197(2), 173\u2013179. https:\/\/doi.org\/10.1007\/s00408-019-00196-6 (2019).","journal-title":"Lung"},{"issue":"1","key":"68641_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-014-0089-y","volume":"15","author":"ES Wan","year":"2014","unstructured":"Wan, E. S. et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir. Res. 15(1), 89. https:\/\/doi.org\/10.1186\/s12931-014-0089-y (2014).","journal-title":"Respir. Res."},{"key":"68641_CR50","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.2147\/COPD.S563250","volume":"20","author":"G Zhao","year":"2025","unstructured":"Zhao, G. et al. All-cause and cause-specific mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 20, 4173\u20134190. https:\/\/doi.org\/10.2147\/COPD.S563250 (2025).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68641-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68641-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68641-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:16:08Z","timestamp":1788974168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-68641-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68641"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-68641-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"28241"}}